HLB bioStep Co.,Ltd.
278650 | KO
Overview
Corporate Details
- ISIN(s):
- KR7278650007
- LEI:
- Country:
- South Korea
- Address:
- 인천광역시 연수구 아카데미로79번길 38 -, 인천광역시
- Website:
- http://hlbbiostep.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-20 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 12.1 KB | ||
| 2025-08-20 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 103.7 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-08-13 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-06-30 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-30 00:00 |
Regulatory Filings
[기재정정]신규시설투자등
|
Korean | 10.7 KB | ||
| 2025-05-27 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 104.4 KB | ||
| 2025-05-22 00:00 |
Transaction in Own Shares
신탁계약해지결과보고서
|
Korean | 19.5 KB | ||
| 2025-05-20 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 11.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-04-30 00:00 |
Regulatory Filings
소속부변경
|
Korean | 3.6 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 30.4 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
대표이사변경
|
Korean | 10.2 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 14.8 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 25.7 KB |
Automate Your Workflow. Get a real-time feed of all HLB bioStep Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for HLB bioStep Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HLB bioStep Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
Spain
IKM
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
Sweden
2CUREX
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
Sweden
ABERA
South Korea
203400
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
South Korea
298380
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
United States of America
ABP
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
United States of America
ABSI
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland
ACHI
Switzerland
ACHI
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
Sweden
ACTI
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG
United States of America
ADAG